New Israeli-led AI model to predict chemotherapy benefit in breast cancer
Technion researchers part of international study that validates fast, accessible alternative to genomic tests using routine pathology samples.
Original Source
Read the full article at Jpost →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.